Cargando…
Treatment Options in Cushing’s Disease
Endogenous Cushing’s syndrome is a grave disease that requires a multidisciplinary and individualized treatment approach for each patient. Approximately 80% of all patients harbour a corticotroph pituitary adenoma (Cushing’s disease) with excessive secretion of adrenocorticotropin-hormone (ACTH) and...
Autores principales: | Rizk, Ahmed, Honegger, Juergen, Milian, Monika, Psaras, Tsambika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273924/ https://www.ncbi.nlm.nih.gov/pubmed/22346367 http://dx.doi.org/10.4137/CMO.S6198 |
Ejemplares similares
-
Individualized medical treatment options in Cushing disease
por: Gilis-Januszewska, Aleksandra, et al.
Publicado: (2022) -
Transcriptome analysis of MENX-associated rat pituitary adenomas identifies novel molecular mechanisms involved in the pathogenesis of human pituitary gonadotroph adenomas
por: Lee, Misu, et al.
Publicado: (2013) -
New options for the medical treatment of Cushing's syndrome
por: Trainer, Peter J.
Publicado: (2013) -
Recurrence after pituitary surgery in adult Cushing’s disease: a systematic review on diagnosis and treatment
por: Braun, Leah T., et al.
Publicado: (2020) -
Chemosensory dysfunction in Cushing’s syndrome
por: Heger, Elena, et al.
Publicado: (2021)